Abstract
The humoral immune response against human T-cell lymphotropic virus type I (HTLV-I) in the central nervous system (CNS) compartment and in the blood was investigated by enzyme immunoassay using 16 synthetic peptides corresponding to HTLV-I core and envelope sequences. We evaluated paired samples of cerebrospinal fluid and serum from HTLV-I seropositive Japanese patients, classified as follows: HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP;n = 39), patients with spinal cord disease ascribed to either HAM/TSP or to some concomitant, HTLV-I-unrelated disease (possible HAM/TSP;n = 6) or carriers without any clinical signs of HAM/TSP (n = 15). HTLV-I-peptide-specific intrathecal antibody synthesis was found in 79% of HAM/TSP patients, but only in 20% of carriers without HAM/TSP. The group of carriers without HAM/TSP showed local synthesis for some peptides (on average 0.3 peptides per patient). In most HAM/TSP patients, however, there was a diverse intrathecal immune response to several HTLV-I synthetic peptides (on average against 3.6 peptides per HAM/TSP patient), most frequently againstgag p19 100–130,env gp21 458–488, andenv gp46 175–199 and 288–317. The intrathecal antibody synthesis against several HTLV-I determinants may represent a pathogenic immune response in HAM/TSP and is possibly related to the infiltration of virus-infected T-cells in the spinal cord.
Similar content being viewed by others
References
Abbas AK, Lichtman AH, Pober JS (1994) Antigen processing and presentation to T lymphocytes. In: Abbas AK, Lichtman AH, Pober JS (eds) Cellular and molecular immunology. Saunders, Philadelphia, pp 116–135
Ceroni M, Piccardo P, Rodgers Johnson P, Mora C, Asher DM, Gajdusek DC, Gibbs CJ Jr (1988) Intrathecal synthesis of IgG antibodies to HTLV-I supports an etiological role for HTLV-I in tropical spastic paraparesis. Ann Neurol 23:S188–191
Chen YA, Lee T, Samuel KP, Okayama A, Tachibana N, Miyoshi I, Papas TS, Essex M (1989) Antibody reactivity to different regions of human T-cell leukemia virus type I gp61 in infected people. J Virol 63:4952–4957
Constantine NT, Callahan JD, Watts DM (1992) HTLV-I and HTLV-II. In: Constantine NT, Callahan JD, Watts DM (eds) Retroviral testing: essentials for quality control and laboratory diagnosis. CRC Press, Boca Raton, pp 103–111
Desgranges C, Souche S, Vemant JC, Smadja D, Vahlne A, Horal P (1994) Identification of novel neutralizationinducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-Isero positive sera. AIDS Res Hum Retroviruses 10:163–173
Feldkamp CS, Smith SW (1987) Practical guide to immunoassay method evaluation. In: Chan DW, Perlstein MT (eds) Immunoassay — a practical guide. Academic Press, San Diego, pp 49–95
Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, The G de (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet II:407–410
Gessain A, Caudie C, Gout O, Vernant JC, Maurs L, Giordano C, Malone G, Tournier-Lasserve E, Essex M, The G de (1988) Intrathecal synthesis of antibodies to human T lymphotropic virus type I and the presence of IgG oligoclonal bands in the cerebrospinal fluid of patients with endemic tropical spastic paraparesis. J Infect Dis 157:1226–1234
Grimaldi LME, Roos RP, Devare SG, Casey JM, Maruo Y, Hamada T, Tashiro K (1988) HTLV-I associated myelopathy: oligoclonal immunoglobulin G bands contain anti-HTLV-I p24 antibody. Ann Neurol 24:727–731
Hino S, Yamaguchi K, Katamine S, Sugiyama H, Amagasaki T, Kinoshita K, Yoshida Y, Doi H, Tsuji Y, Miyamoto T (1985) Mother-to-child transmission of human T-cell leukemia virus type-1. Jpn J Cancer Res 76:474–480
Ida H, Kurata A, Eguchi K, Kawakami A, Migita K, Fukuda T, Nakamura T, Kusumoto Y, Berzofsky JA, Nagataki S (1991) Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals. J Clin Immunol 11:143–151
Ijichi S, Izumo S, Eiraku N, Machigashira K, Kubota R, Nagai M, Ikegami N, Kashio N, Umehara F, Maruyama I, Osame M (1993) An autoaggressive process against bystander tissues in HTLV-I-infected individuals: a possible pathomechanism of HAM/TSP. Med Hypotheses 41:542–547
Inoue Y, Kuroda N, Shiraki H, Sato H, Maeda Y (1992) Neutralizing activity of human antibodies against the structural protein of human T-cell lymphotropic virus type I. Int J Cancer 52:877–880
Iwasaki Y (1990) Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J Neurol Sci 96:103–123
Jacobson S, Gupta A, Mattson D, Mingioli E, McFarlin DE (1990) Immunological studies in tropical spastic paraparesis. Ann Neurol 27:149–156
Jacobson S, Shida H, McFarlin DE, Fauci A, Koenig S (1990) Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348:245–248
Jacobson S, Reuben JS, Streilein RD, Palker TJ (1991) Induction of CD4+, human T lymphotropic virus type-lspecific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1. J Immunol 146:1155–1162
Kitze B, Puccioni-Sohler M, Schäffner J, Rieckmann P, Weber T, Felgenhauer K, Bodemer W (1995) Specificity of intrathecal IgG synthesis for HTLV-I core and envelope proteins in HTLV-I associated myelopathy. Acta Neurol Scand 92:213–217
Lal RB, Giam C, Coligan JE, Rudolph DL (1994) Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy. J Infect Dis 169:496–503
Link H, Cruz M, Gessain A, Gout O, The G de, Kam Hansen S (1989) Chronic progressive myelopathy associated with HTLV-I: oligoclonal IgG and anti-HTLV-I IgG antibodies in cerebrospinal fluid and serum. Neurology 39:1566–1572
McLean BN, Rudge P, Thompson EJ (1989) Viral specific IgG and IgM antibodies in the CSF of patients with tropical spastic paraparesis. J Neurol 236:351–352
Nakamura M, Kuroki M, Kira J, Itoyama Y, Shiraki H, Kuroda N, Washitani Y, Nakano S, Nagafuchi S, Anzai K, Tatsumoto T, Esaki T, Maeda Y, Niho Y (1991) Elevated antibodies to synthetic peptides of HTLV-I envelope transmembrane glycoproteins in patients with HAM/TSP. J Neuroimmunol 35:167–177
Osame M (1990) Review of WHO Kagoshima Meeting and Diagnostic Guidelines for HAM/TSP. In: Blattner WA (ed) Human retrovirology: HTLV. Raven Press, New York, pp 191–197
Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. (1986) HTLV-I associated myelopathy. A new clinical entity. Lancet 1:1031–1032
Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A (1987) Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol 21:117–122
Palker TJ, Tanner ME, Scearce RM, Streilein RD, Clark ME, Haynes BF (1989) Mapping of immunogenic regions of human T cell leukemia virus tpye I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46. J Immunol 142:971–978
Parker CE, Daenke S, Nightingale S, Bangham CR (1992) Activated, HTLV-I-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 188:628–636
Reiber H., Felgenhauer K (1987) Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta 163:319–328
Reiber H, Lange P (1991) Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 37:1153–1160
Suehara M, Izumo S, Kumamoto I, Osame M (1992) Significance of antiHTLV-I antibody in cerebrospinal fluid in diagnosis of HTLV-I associated myelopathy (HAM). Rinsho Byori 40:311–316
Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H (1977) Adult T-cell leukemia: clinical and hematological features of 16 cases. Blood 50:481–492
Umehara F, Izumo S, Nakagawa M, Ronquillo AT, Takahashi K, Matsumuro K, Sato E, Osame M (1993) Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 52:424–430
Usuku K, Sonoda S, Osame M, Yashiki S, Takahashi K, Matsumoto M, Sawada T, Tsuji K, Tara M, Igata A (1988) HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann Neurol 23:S143–150
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kitze, B., Usuku, K., Izumo, S. et al. Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy. J Neurol 243, 393–400 (1996). https://doi.org/10.1007/BF00868998
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00868998